Cargando…

Metabolic Acidosis Due To Pyroglutamic Acid

Metabolic acidosis is a common clinical disturbance due to increased plasma acidity caused by a primary decrease in serum HCO3- concentration. It is classified as normal or high anion gap metabolic acidosis. High anion gap metabolic acidosis can result from either a decrease in unmeasured cations (K...

Descripción completa

Detalles Bibliográficos
Autores principales: Serpa, Maria João, Falcão, Luís, Franco, Susana, Repolho, Diana, Ferreira, Nuno Ribeiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SMC Media Srl 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346886/
https://www.ncbi.nlm.nih.gov/pubmed/30755980
http://dx.doi.org/10.12890/2018_000949
_version_ 1783389842381471744
author Serpa, Maria João
Falcão, Luís
Franco, Susana
Repolho, Diana
Ferreira, Nuno Ribeiro
author_facet Serpa, Maria João
Falcão, Luís
Franco, Susana
Repolho, Diana
Ferreira, Nuno Ribeiro
author_sort Serpa, Maria João
collection PubMed
description Metabolic acidosis is a common clinical disturbance due to increased plasma acidity caused by a primary decrease in serum HCO3- concentration. It is classified as normal or high anion gap metabolic acidosis. High anion gap metabolic acidosis can result from either a decrease in unmeasured cations (K(+), Ca2(+), Mg2(+)) or an increase in unmeasured anions (PO(4)(3−), albumin). However, other anions such as lactic acid or keto acids may cause this acid-base disorder. It can also result from renal failure and intoxication (salicylate, methanol, ethylene glycol), or more rarely, from massive rhabdomyolysis and pyroglutamic (5-oxoproline) acidemia. Acidemia due to pyroglutamic acid should be considered when no other aetiology is found. High anion gap metabolic acidosis is diagnosed in children with inherited defects in enzymes of the γ-glutamyl cycle. In adults, this disorder from pyroglutamic acid has been described in association with chronic acetaminophen misuse. We report a case of pyroglutamic acidosis in a woman with acute misuse of acetaminophen concurrent with chronic use. LEARNING POINT: Paracetamol is an easily available drug with potentially harmful consequences. Accumulation of pyroglutamic acid (5-oxoproline) may be a cause of high anion gap metabolic acidosis. Reporting cases of 5-oxoprolinemia acidosis contributes to better understanding of the condition.
format Online
Article
Text
id pubmed-6346886
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SMC Media Srl
record_format MEDLINE/PubMed
spelling pubmed-63468862019-02-12 Metabolic Acidosis Due To Pyroglutamic Acid Serpa, Maria João Falcão, Luís Franco, Susana Repolho, Diana Ferreira, Nuno Ribeiro Eur J Case Rep Intern Med Articles Metabolic acidosis is a common clinical disturbance due to increased plasma acidity caused by a primary decrease in serum HCO3- concentration. It is classified as normal or high anion gap metabolic acidosis. High anion gap metabolic acidosis can result from either a decrease in unmeasured cations (K(+), Ca2(+), Mg2(+)) or an increase in unmeasured anions (PO(4)(3−), albumin). However, other anions such as lactic acid or keto acids may cause this acid-base disorder. It can also result from renal failure and intoxication (salicylate, methanol, ethylene glycol), or more rarely, from massive rhabdomyolysis and pyroglutamic (5-oxoproline) acidemia. Acidemia due to pyroglutamic acid should be considered when no other aetiology is found. High anion gap metabolic acidosis is diagnosed in children with inherited defects in enzymes of the γ-glutamyl cycle. In adults, this disorder from pyroglutamic acid has been described in association with chronic acetaminophen misuse. We report a case of pyroglutamic acidosis in a woman with acute misuse of acetaminophen concurrent with chronic use. LEARNING POINT: Paracetamol is an easily available drug with potentially harmful consequences. Accumulation of pyroglutamic acid (5-oxoproline) may be a cause of high anion gap metabolic acidosis. Reporting cases of 5-oxoprolinemia acidosis contributes to better understanding of the condition. SMC Media Srl 2018-10-24 /pmc/articles/PMC6346886/ /pubmed/30755980 http://dx.doi.org/10.12890/2018_000949 Text en © EFIM 2018 This article is licensed under a Commons Attribution Non-Commercial 4.0 License (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Articles
Serpa, Maria João
Falcão, Luís
Franco, Susana
Repolho, Diana
Ferreira, Nuno Ribeiro
Metabolic Acidosis Due To Pyroglutamic Acid
title Metabolic Acidosis Due To Pyroglutamic Acid
title_full Metabolic Acidosis Due To Pyroglutamic Acid
title_fullStr Metabolic Acidosis Due To Pyroglutamic Acid
title_full_unstemmed Metabolic Acidosis Due To Pyroglutamic Acid
title_short Metabolic Acidosis Due To Pyroglutamic Acid
title_sort metabolic acidosis due to pyroglutamic acid
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346886/
https://www.ncbi.nlm.nih.gov/pubmed/30755980
http://dx.doi.org/10.12890/2018_000949
work_keys_str_mv AT serpamariajoao metabolicacidosisduetopyroglutamicacid
AT falcaoluis metabolicacidosisduetopyroglutamicacid
AT francosusana metabolicacidosisduetopyroglutamicacid
AT repolhodiana metabolicacidosisduetopyroglutamicacid
AT ferreiranunoribeiro metabolicacidosisduetopyroglutamicacid